| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AngioGenex, Inc. | Director, CHAIRMAN, 10%+ Owner | Common Stock | 7,507,827 | 31 Aug 2021 | Direct | ||
| AngioGenex, Inc. | Director, CHAIRMAN, 10%+ Owner | Convertible Note | 5,240,000 | 02 Nov 2021 | Direct | ||
| AngioGenex, Inc. | Director, CHAIRMAN, 10%+ Owner | Stock Option | 5,000,000 | 02 Sep 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AGGX | AngioGenex, Inc. | 31 Dec 2021 | 11 | +$134,362,775,000 | 5 | Director, CHAIRMAN, 10%+ Owner | 15 Feb 2022, 15:41 |